XORTX’s presentation will be recorded and available after the conference on the Company’s website. About XORTX Therapeutics Inc.

Among patients with gout in the US, Black individuals and those living in the South were associated with reduced adherence to allopurinol.

The journey of Takeda’s gout med Uloric—which turned rocky in recent years—has come to an end in the U.S. | Following some ...

Rheumatologists report largely adhering to American College of Rheumatology guidelines for gout management, but show notable ...

FOR centuries, gout has been a deeply misunderstood disease, associated only with jolly, indulgent, and often big men. When ...

Drugmakers raised the list prices on 575 name-brand drugs in just the first two days of the new year, according to drug price research firm 46brooklyn. Drugs for diabetes, HIV, cancer saw price ...

One regimen to consider for those commencing allopurinol at an early stage of gout presentation in a patient ... effects such as neuromyopathy [28] or drug interactions, as noted above.

Gout flares are commonly underreported among U.S. adults with gout, according to a study published in the January issue of ACR Open Rheumatology. Jasvinder A. Singh, M.D., M.P.H., from the Michael ...

The EULAR evidence-based recommendations for gout reported a future research agenda, which included research on the efficacy of educational programmes for lifestyle modifications (e.g., weight ...

Help Register Login Login Hi, %{firstName}% Hi, %{firstName}% Games Car rental More than 90 percent of adults aged 65 and older take at least one prescription medication, with 66 percent of people in ...

Pending FDA feedback, the Company will also seek FDA orphan drug designation (“ODD”) and NDA marketing approval for the XRx-026 program. Previously, oxypurinol was granted ODD for allopurinol ...